Suppr超能文献

华法林对凝血功能稳定且依从性受监测患者血浆中维生素K依赖性凝血因子浓度的影响。

Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance.

作者信息

Kumar S, Haigh J R, Tate G, Boothby M, Joanes D N, Davies J A, Roberts B E, Feely M P

机构信息

University Department of Medicine, General Infirmary, Leeds.

出版信息

Br J Haematol. 1990 Jan;74(1):82-5. doi: 10.1111/j.1365-2141.1990.tb02542.x.

Abstract

There is a discrepancy in the results of reported studies of levels of vitamin K dependent coagulation factors in patients on warfarin therapy. This may have arisen partly because of the problem of assuring compliance with therapy in outpatients. The plasma concentrations of the vitamin K dependent clotting factors II, VII, IX and X were studied in 23 outpatients whose adherence to prescribed warfarin therapy was determined using a pharmacological indicator of compliance. In these patients, who were shown to have consistently good compliance and stable anticoagulant control over a period of 3-6 months, the activities in plasma of the four coagulation factors were not equally suppressed. Factor IX levels were significantly greater than those of factor VII (P less than 0.0001) which in turn were significantly greater than the levels of factor II (P less than 0.0001) or factor X (P less than 0.0001). There was no significant difference between the levels of factors II and X which were depressed to a similar extent. The proportion of variability of the International Normalized Ratio (INR) explained by linear regression was 51-77% and a model was derived to predict the INR from the mean of the levels of the four clotting factors. The concentrations of the coagulation factors II, VII, IX and X are likely to be highly dependent on the degree of compliance with warfarin therapy which should be taken into account when investigating the behaviour of these factors.

摘要

关于接受华法林治疗患者的维生素K依赖凝血因子水平,已发表研究的结果存在差异。这可能部分是由于确保门诊患者遵医嘱治疗存在困难。对23名门诊患者的维生素K依赖凝血因子II、VII、IX和X的血浆浓度进行了研究,使用一种遵医嘱治疗的药理学指标来确定他们对规定华法林治疗的依从性。在这些被证明在3至6个月期间始终具有良好依从性且抗凝控制稳定的患者中,四种凝血因子在血浆中的活性并未受到同等程度的抑制。因子IX水平显著高于因子VII水平(P<0.0001),而因子VII水平又显著高于因子II水平(P<0.0001)或因子X水平(P<0.0001)。因子II和X的水平下降程度相似,二者之间无显著差异。线性回归所解释的国际标准化比值(INR)变异性比例为51%-77%,并推导了一个根据四种凝血因子水平均值预测INR的模型。凝血因子II、VII、IX和X的浓度可能高度依赖于华法林治疗的依从程度,在研究这些因子的行为时应考虑到这一点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验